PSA PROGRESSION
Clinical trials for PSA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new PSA PROGRESSION trials appear
Sign up with your email to follow new studies for PSA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a mushroom supplement slow prostate cancer?
Disease control OngoingThis study tests whether a white button mushroom supplement can lower PSA levels in men with prostate cancer that has returned after treatment or is low-risk and being watched. About 133 men will take the supplement or be monitored as usual. The goal is to see if the mushroom aff…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 09:49 UTC
-
New hope for men with hard-to-treat prostate cancer: adding immunotherapy to existing drug
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab can help men whose advanced prostate cancer has stopped responding to the hormone therapy enzalutamide. About 58 men with castration-resistant prostate cancer that has spread will receive pembrolizumab while con…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New hope for tough prostate cancer: drug cocktail trial underway
Disease control OngoingThis study tests different combinations of approved drugs to treat men with advanced prostate cancer that has spread and no longer responds to hormone therapy. About 196 men will receive either a standard hormone-blocking combo or that combo plus an immunotherapy or chemotherapy …
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Precision radiation after prostate surgery shows promise in cancer control
Disease control OngoingThis study tests a precise type of radiation called stereotactic body radiotherapy (SBRT) in 92 men who had prostate cancer surgery but still have signs of cancer, like rising PSA levels. The goal is to see if SBRT can stop the cancer from coming back while limiting side effects.…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 18, 2026 12:01 UTC